Application of LC-UV/MS Workflows for GLP-1 Analogs

This technical report discusses the application of LC-UV/MS workflows to enhance the efficiency of impurity profiling for GLP-1 analogs, which are increasingly utilized as treatments for type 2 diabetes and obesity. The report outlines the challenges faced in the production and analysis of these analogs, particularly regarding impurity identification and stability monitoring. It emphasizes the advantages of integrating LC-UV/MS platforms in analytical laboratories, detailing how these systems can alleviate workloads during method development and manufacturing. The study presents experimental results demonstrating the effectiveness of the ACQUITY QDa II Mass Detector in identifying impurities generated under various stress conditions, including thermal and oxidative stress. The findings indicate that the use of orthogonal mass data can significantly improve decision-making processes in laboratories, ultimately leading to increased productivity and better compliance with regulatory standards. The report serves as a comprehensive resource for understanding the methodologies and benefits of employing LC-UV/MS workflows in the context of GLP-1 analog production.